The powder absorbable hemostat market size has grown strongly in recent years. It will grow from $2.48 billion in 2025 to $2.66 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing surgical procedures, rising awareness about blood loss management, availability of collagen and gelatin materials, demand for quick hemostasis, adoption of advanced surgical tools.
The powder absorbable hemostat market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to innovations in powder hemostat formulations, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, increasing geriatric population, rising healthcare expenditure. Major trends in the forecast period include minimally invasive surgical techniques, rapid hemostasis solutions, biocompatible & bioresorbable materials, customizable powder hemostat formulations, growth in ambulatory & outpatient surgical procedures.
The growing number of surgeries is expected to drive the expansion of the powder absorbable hemostat market in the coming years. Surgeries are medical procedures that employ manual or instrument-based techniques to treat injuries, manage illnesses, or improve physical function. The increase in surgical procedures is fueled by the rising prevalence of chronic diseases, which often require surgical intervention for effective management. This growing surgical volume creates a higher demand for efficient bleeding control, thereby boosting the use of powder absorbable hemostats. Their rapid and precise hemostatic action is particularly beneficial in delicate or minimally invasive surgeries, enhancing patient outcomes. For example, in March 2023, data from the British Association of Aesthetic Plastic Surgeons, a UK-based surgical body, revealed that 31,057 cosmetic surgeries were performed in the UK in 2022, representing a significant 102% increase compared to the previous year. Consequently, the rising number of surgeries is fueling the growth of the powder absorbable hemostat market.
Key players in the powder absorbable hemostat market are focusing on creating advanced products, such as plant-based polysaccharide absorbable hemostat powders, to improve clotting effectiveness and enhance safety during surgeries. This type of hemostatic powder is derived from purified natural starch and works by rapidly absorbing blood to initiate clot formation. It is fully bioresorbable, eliminating the need for removal after use. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT, a starch-based passive absorbable hemostatic powder, in the United States. Designed for patients with intact coagulation systems, PERCLOT controls mild surgical bleeding by quickly absorbing water to form a gelled adhesive matrix that acts as a mechanical barrier, promoting the buildup of platelets, red blood cells, and coagulation proteins. This product adds to Baxter’s hemostat offerings by helping reduce blood transfusions and complications, while also lowering overall healthcare costs.
In April 2025, Olympus Canada Inc., a Canadian medical technology provider, formed a partnership with EndoClot Plus, Inc. to enhance gastrointestinal (GI) care through advanced endoscopic solutions. This collaboration aims to expand Olympus’ GI product line by delivering cutting-edge hemostatic technologies that improve clinical outcomes in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) procedures throughout Canada. EndoClot Plus, Inc. is a US-based manufacturer specializing in powder absorbable hemostat systems.
Major companies operating in the powder absorbable hemostat market are Johnson & Johnson, Baxter International, Integra LifeSciences Corporation, Hangzhou Singclean Medical Products Co. Ltd, Gelita Medical GmbH, Algan Grup Sağlık Hizmetleri, Ferrosan Medical Devices, Hemostasis LLC, CuraMedical B.V., BioCer Entwicklungs GmbH, Medcura Inc., Starch Medical Inc., Aegis Lifesciences, Hemostat Medical GmbH, B. Braun Melsungen AG, Pfizer Hospital Products, Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Anika Therapeutics Inc., Teleflex Medical, Ethicon Biosurgery, Z Medica LLC.
North America was the largest region in the powder absorbable hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the powder absorbable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the powder absorbable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the powder absorbable hemostat market by increasing the cost of imported raw materials such as collagen, gelatin, and cellulose, thereby raising production expenses. Surgical powder formulations and combination hemostats are particularly affected, especially in North America and Europe where imports are significant. Some regions may benefit from local manufacturing incentives or tariff exemptions, which encourage domestic production and innovation in bioresorbable hemostat solutions, partially offsetting the negative effects of tariffs.
The powder absorbable hemostat market research report is one of a series of new reports that provides powder absorbable hemostat market statistics, including powder absorbable hemostat industry global market size, regional shares, competitors with a powder absorbable hemostat market share, detailed powder absorbable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the powder absorbable hemostat industry. This powder absorbable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An absorbable powder hemostat is a sterile, bioresorbable material designed to control bleeding during surgical procedures. Made from polysaccharides derived from plants or animals, it quickly absorbs blood and facilitates clot formation. Its powdered form enables easy application to uneven or hard-to-reach areas in surgery. The main purpose of this product is to achieve rapid hemostasis and reduce the risks associated with bleeding during surgery.
The primary categories of absorbable powder hemostats include collagen-based, gelatin-based, cellulose-based, and combination types. Collagen-based powders, sourced from bovine or porcine tissues, help accelerate clotting by activating platelets and are commonly used for effective bleeding control in surgeries. These hemostats come in various forms, including powders, ready-to-use mixes, pre-mixed, and custom formulations, and are distributed through multiple channels such as direct sales, distributors, online platforms, and pharmacies. They are applied in diverse medical fields like surgical procedures, trauma care, orthopedic operations, and cardiovascular surgeries, and are utilized by a range of end-users including hospitals, ambulatory surgical centers, specialty clinics, and outpatient surgery facilities.
The powder absorbable hemostat market consists of sales of chitosan-based hemostats, kaolin-based hemostats, and oxidized regenerated cellulose (ORC) powders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The powder absorbable hemostat market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to innovations in powder hemostat formulations, growth in minimally invasive surgeries, expansion of ambulatory surgical centers, increasing geriatric population, rising healthcare expenditure. Major trends in the forecast period include minimally invasive surgical techniques, rapid hemostasis solutions, biocompatible & bioresorbable materials, customizable powder hemostat formulations, growth in ambulatory & outpatient surgical procedures.
The growing number of surgeries is expected to drive the expansion of the powder absorbable hemostat market in the coming years. Surgeries are medical procedures that employ manual or instrument-based techniques to treat injuries, manage illnesses, or improve physical function. The increase in surgical procedures is fueled by the rising prevalence of chronic diseases, which often require surgical intervention for effective management. This growing surgical volume creates a higher demand for efficient bleeding control, thereby boosting the use of powder absorbable hemostats. Their rapid and precise hemostatic action is particularly beneficial in delicate or minimally invasive surgeries, enhancing patient outcomes. For example, in March 2023, data from the British Association of Aesthetic Plastic Surgeons, a UK-based surgical body, revealed that 31,057 cosmetic surgeries were performed in the UK in 2022, representing a significant 102% increase compared to the previous year. Consequently, the rising number of surgeries is fueling the growth of the powder absorbable hemostat market.
Key players in the powder absorbable hemostat market are focusing on creating advanced products, such as plant-based polysaccharide absorbable hemostat powders, to improve clotting effectiveness and enhance safety during surgeries. This type of hemostatic powder is derived from purified natural starch and works by rapidly absorbing blood to initiate clot formation. It is fully bioresorbable, eliminating the need for removal after use. For instance, in July 2023, Baxter International Inc., a US-based healthcare company, launched PERCLOT, a starch-based passive absorbable hemostatic powder, in the United States. Designed for patients with intact coagulation systems, PERCLOT controls mild surgical bleeding by quickly absorbing water to form a gelled adhesive matrix that acts as a mechanical barrier, promoting the buildup of platelets, red blood cells, and coagulation proteins. This product adds to Baxter’s hemostat offerings by helping reduce blood transfusions and complications, while also lowering overall healthcare costs.
In April 2025, Olympus Canada Inc., a Canadian medical technology provider, formed a partnership with EndoClot Plus, Inc. to enhance gastrointestinal (GI) care through advanced endoscopic solutions. This collaboration aims to expand Olympus’ GI product line by delivering cutting-edge hemostatic technologies that improve clinical outcomes in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) procedures throughout Canada. EndoClot Plus, Inc. is a US-based manufacturer specializing in powder absorbable hemostat systems.
Major companies operating in the powder absorbable hemostat market are Johnson & Johnson, Baxter International, Integra LifeSciences Corporation, Hangzhou Singclean Medical Products Co. Ltd, Gelita Medical GmbH, Algan Grup Sağlık Hizmetleri, Ferrosan Medical Devices, Hemostasis LLC, CuraMedical B.V., BioCer Entwicklungs GmbH, Medcura Inc., Starch Medical Inc., Aegis Lifesciences, Hemostat Medical GmbH, B. Braun Melsungen AG, Pfizer Hospital Products, Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Anika Therapeutics Inc., Teleflex Medical, Ethicon Biosurgery, Z Medica LLC.
North America was the largest region in the powder absorbable hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the powder absorbable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the powder absorbable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the powder absorbable hemostat market by increasing the cost of imported raw materials such as collagen, gelatin, and cellulose, thereby raising production expenses. Surgical powder formulations and combination hemostats are particularly affected, especially in North America and Europe where imports are significant. Some regions may benefit from local manufacturing incentives or tariff exemptions, which encourage domestic production and innovation in bioresorbable hemostat solutions, partially offsetting the negative effects of tariffs.
The powder absorbable hemostat market research report is one of a series of new reports that provides powder absorbable hemostat market statistics, including powder absorbable hemostat industry global market size, regional shares, competitors with a powder absorbable hemostat market share, detailed powder absorbable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the powder absorbable hemostat industry. This powder absorbable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An absorbable powder hemostat is a sterile, bioresorbable material designed to control bleeding during surgical procedures. Made from polysaccharides derived from plants or animals, it quickly absorbs blood and facilitates clot formation. Its powdered form enables easy application to uneven or hard-to-reach areas in surgery. The main purpose of this product is to achieve rapid hemostasis and reduce the risks associated with bleeding during surgery.
The primary categories of absorbable powder hemostats include collagen-based, gelatin-based, cellulose-based, and combination types. Collagen-based powders, sourced from bovine or porcine tissues, help accelerate clotting by activating platelets and are commonly used for effective bleeding control in surgeries. These hemostats come in various forms, including powders, ready-to-use mixes, pre-mixed, and custom formulations, and are distributed through multiple channels such as direct sales, distributors, online platforms, and pharmacies. They are applied in diverse medical fields like surgical procedures, trauma care, orthopedic operations, and cardiovascular surgeries, and are utilized by a range of end-users including hospitals, ambulatory surgical centers, specialty clinics, and outpatient surgery facilities.
The powder absorbable hemostat market consists of sales of chitosan-based hemostats, kaolin-based hemostats, and oxidized regenerated cellulose (ORC) powders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Powder Absorbable Hemostat Market Characteristics
3. Powder Absorbable Hemostat Market Supply Chain Analysis
4. Global Powder Absorbable Hemostat Market Trends and Strategies
5. Powder Absorbable Hemostat Market Analysis of End Use Industries
7. Global Powder Absorbable Hemostat Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Powder Absorbable Hemostat Total Addressable Market (TAM) Analysis for the Market
9. Powder Absorbable Hemostat Market Segmentation
10. Powder Absorbable Hemostat Market Regional and Country Analysis
11. Asia-Pacific Powder Absorbable Hemostat Market
12. China Powder Absorbable Hemostat Market
13. India Powder Absorbable Hemostat Market
14. Japan Powder Absorbable Hemostat Market
15. Australia Powder Absorbable Hemostat Market
16. Indonesia Powder Absorbable Hemostat Market
17. South Korea Powder Absorbable Hemostat Market
18. Taiwan Powder Absorbable Hemostat Market
19. South East Asia Powder Absorbable Hemostat Market
20. Western Europe Powder Absorbable Hemostat Market
21. UK Powder Absorbable Hemostat Market
22. Germany Powder Absorbable Hemostat Market
23. France Powder Absorbable Hemostat Market
24. Italy Powder Absorbable Hemostat Market
25. Spain Powder Absorbable Hemostat Market
26. Eastern Europe Powder Absorbable Hemostat Market
27. Russia Powder Absorbable Hemostat Market
28. North America Powder Absorbable Hemostat Market
29. USA Powder Absorbable Hemostat Market
30. Canada Powder Absorbable Hemostat Market
31. South America Powder Absorbable Hemostat Market
32. Brazil Powder Absorbable Hemostat Market
33. Middle East Powder Absorbable Hemostat Market
34. Africa Powder Absorbable Hemostat Market
36. Powder Absorbable Hemostat Market Competitive Landscape and Company Profiles
37. Powder Absorbable Hemostat Market Other Major and Innovative Companies
40. Powder Absorbable Hemostat Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Powder Absorbable Hemostat Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses powder absorbable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for powder absorbable hemostat? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The powder absorbable hemostat market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Collagen-Based Hemostats; Gelatin-Based Hemostats; Cellulose-Based Hemostats; Combination Hemostats2) By Formulation: Powder Formulations; Ready-To-Use Formulations; Pre-Mixed Formulations; Custom Formulations
3) By Distribution Channel: Direct Sales; Distributors
4) By Application: Surgical Procedures; Trauma Care; Orthopedic Surgeries; Cardiovascular Surgeries
5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Outpatient Surgery Facilities; Other End-Users
Subsegments:
1) By Collagen-Based Hemostats: Bovine Collagen Hemostats; Porcine Collagen Hemostats; Synthetic Collagen Hemostats2) By Gelatin-Based Hemostats: Porcine Gelatin Hemostats; Bovine Gelatin Hemostats; Recombinant Gelatin Hemostats
3) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Hemostats; Oxidized Cellulose Hemostats; Carboxymethyl Cellulose Hemostats
4) By Combination Hemostats: Collagen + Gelatin Combination Hemostats; Collagen + Cellulose Combination Hemostats; Gelatin + Cellulose Combination Hemostats; Multi-component (Collagen + Gelatin + Cellulose) Hemostats
Companies Mentioned: Johnson & Johnson; Baxter International; Integra LifeSciences Corporation; Hangzhou Singclean Medical Products Co. Ltd; Gelita Medical GmbH; Algan Grup Sağlık Hizmetleri; Ferrosan Medical Devices; Hemostasis LLC; CuraMedical B.V.; BioCer Entwicklungs GmbH; Medcura Inc.; Starch Medical Inc.; Aegis Lifesciences; Hemostat Medical GmbH; B. Braun Melsungen AG; Pfizer Hospital Products; Advanced Medical Solutions Group plc; Marine Polymer Technologies Inc.; Anika Therapeutics Inc.; Teleflex Medical; Ethicon Biosurgery; Z Medica LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Powder Absorbable Hemostat market report include:- Johnson & Johnson
- Baxter International
- Integra LifeSciences Corporation
- Hangzhou Singclean Medical Products Co. Ltd
- Gelita Medical GmbH
- Algan Grup Sağlık Hizmetleri
- Ferrosan Medical Devices
- Hemostasis LLC
- CuraMedical B.V.
- BioCer Entwicklungs GmbH
- Medcura Inc.
- Starch Medical Inc.
- Aegis Lifesciences
- Hemostat Medical GmbH
- B. Braun Melsungen AG
- Pfizer Hospital Products
- Advanced Medical Solutions Group plc
- Marine Polymer Technologies Inc.
- Anika Therapeutics Inc.
- Teleflex Medical
- Ethicon Biosurgery
- Z Medica LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.66 Billion |
| Forecasted Market Value ( USD | $ 3.5 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
